Literature DB >> 23806799

E2F1 effects on osteoblast differentiation and mineralization are mediated through up-regulation of frizzled-1.

Shibing Yu1, Laura M Yerges-Armstrong, Yanxia Chu, Joseph M Zmuda, Yingze Zhang.   

Abstract

Frizzled homolog 1 (FZD1) is a transmembrane receptor that mediates Wnt signaling. The transcriptional regulation of FZD1 and the role of FZD1 in osteoblast biology are not well understood. We examined the role of E2F1 in FZD1 promoter activation and osteoblast differentiation and mineralization. A putative E2F1 binding site in the FZD1 promoter region was initially identified in silico and characterized further in Saos2 cells in vitro by chromatin immunoprecipitation (ChIP), electrophoretic mobility shift (EMSA) and promoter reporter assays. Over-expression of E2F1 transactivated the FZD1 promoter and increased endogenous FZD1 mRNA and protein levels in Saos2 cells. Over-expression of E2F1 in Saos2 cells up-regulated osteoblast differentiation markers alkaline phosphatase (ALP), type I collagen α (COL1A), and osteocalcin (OCN). Furthermore, E2F1 over-expression enhanced mineralization of differentiated Saos2 cells, whereas siRNA knockdown of FZD1 diminished the effects of E2F1 on osteoblast mineralization. The effects of E2F1 on FZD1 expression and osteoblast mineralization were further confirmed in normal human FOB osteoblasts. Taken together, our experiments demonstrate a role of E2F1 in osteoblast differentiation and mineralization and suggest that FZD1 is required, in part, for E2F1 regulation of osteoblast mineralization.
© 2013.

Entities:  

Keywords:  E2F1; Frizzled homology1 (FZD1); Mineralization; Osteoblasts

Mesh:

Substances:

Year:  2013        PMID: 23806799      PMCID: PMC3758927          DOI: 10.1016/j.bone.2013.06.019

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  31 in total

1.  E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8.

Authors:  Erick J Morris; Jun-Yuan Ji; Fajun Yang; Luisa Di Stefano; Anabel Herr; Nam-Sung Moon; Eun-Jeong Kwon; Kevin M Haigis; Anders M Näär; Nicholas J Dyson
Journal:  Nature       Date:  2008-09-14       Impact factor: 49.962

2.  Role of non-canonical Wnt signaling in osteoblast maturation on microstructured titanium surfaces.

Authors:  Rene Olivares-Navarrete; Sharon L Hyzy; Daphne L Hutton; Ginger R Dunn; Christoph Appert; Barbara D Boyan; Zvi Schwartz
Journal:  Acta Biomater       Date:  2011-02-23       Impact factor: 8.947

3.  Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts.

Authors:  Rongrong Zhang; Babatunde O Oyajobi; Stephen E Harris; Di Chen; Christopher Tsao; Hong-Wen Deng; Ming Zhao
Journal:  Bone       Date:  2012-09-29       Impact factor: 4.398

4.  Functional and association analysis of frizzled 1 (FZD1) promoter haplotypes with femoral neck geometry.

Authors:  Yingze Zhang; Allison L Kuipers; Laura M Yerges-Armstrong; Cara S Nestlerode; Zhao Jin; Victor W Wheeler; Alan L Patrick; Clareann H Bunker; Joseph M Zmuda
Journal:  Bone       Date:  2010-01-04       Impact factor: 4.398

5.  General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2.

Authors:  Shibing Yu; Yu Jiang; Deborah L Galson; Min Luo; Yumei Lai; Yi Lu; Hong-Jiao Ouyang; Jian Zhang; Guozhi Xiao
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

6.  Functional characterization of genetic variation in the Frizzled 1 (FZD1) promoter and association with bone phenotypes: more to the LRP5 story?

Authors:  Laura M Yerges; Yingze Zhang; Jane A Cauley; Candace M Kammerer; Cara S Nestlerode; Victor W Wheeler; Alan L Patrick; Clareann H Bunker; Susan P Moffett; Robert E Ferrell; Joseph M Zmuda
Journal:  J Bone Miner Res       Date:  2009-01       Impact factor: 6.741

7.  Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling.

Authors:  Bing Yu; Xiaoli Zhao; Chaozhe Yang; Janet Crane; Lingling Xian; William Lu; Mei Wan; Xu Cao
Journal:  J Bone Miner Res       Date:  2012-09       Impact factor: 6.741

8.  Genome-wide analysis of transcription factor E2F1 mutant proteins reveals that N- and C-terminal protein interaction domains do not participate in targeting E2F1 to the human genome.

Authors:  Alina R Cao; Roman Rabinovich; Maoxiong Xu; Xiaoqin Xu; Victor X Jin; Peggy J Farnham
Journal:  J Biol Chem       Date:  2011-02-10       Impact factor: 5.157

9.  Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bone.

Authors:  Shibing Yu; Renny T Franceschi; Min Luo; Jie Fan; Di Jiang; Huiling Cao; Tae-Geon Kwon; Yumei Lai; Jian Zhang; Kenneth Patrene; Kurt Hankenson; G David Roodman; Guozhi Xiao
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

10.  atf4 promotes β-catenin expression and osteoblastic differentiation of bone marrow mesenchymal stem cells.

Authors:  Shibing Yu; Ke Zhu; Yumei Lai; Zhongfang Zhao; Jie Fan; Hee-Jeong Im; Di Chen; Guozhi Xiao
Journal:  Int J Biol Sci       Date:  2013-02-27       Impact factor: 6.580

View more
  12 in total

1.  High-throughput analysis reveals novel maternal germline RNAs crucial for primordial germ cell preservation and proper migration.

Authors:  Dawn A Owens; Amanda M Butler; Tristan H Aguero; Karen M Newman; Derek Van Booven; Mary Lou King
Journal:  Development       Date:  2017-01-15       Impact factor: 6.868

2.  Loss of Twist1 in the Mesenchymal Compartment Promotes Increased Fibrosis in Experimental Lung Injury by Enhanced Expression of CXCL12.

Authors:  Jiangning Tan; John R Tedrow; Mehdi Nouraie; Justin A Dutta; David T Miller; Xiaoyun Li; Shibing Yu; Yanxia Chu; Brenda Juan-Guardela; Naftali Kaminski; Kritika Ramani; Partha S Biswas; Yingze Zhang; Daniel J Kass
Journal:  J Immunol       Date:  2017-02-08       Impact factor: 5.422

3.  BK Knockout by TALEN-Mediated Gene Targeting in Osteoblasts: KCNMA1 Determines the Proliferation and Differentiation of Osteoblasts.

Authors:  Hongya Hei; Jianjun Gao; Jibin Dong; Jie Tao; Lulu Tian; Wanma Pan; Hongyu Wang; Xuemei Zhang
Journal:  Mol Cells       Date:  2016-06-21       Impact factor: 5.034

4.  Old age and the associated impairment of bones' adaptation to loading are associated with transcriptomic changes in cellular metabolism, cell-matrix interactions and the cell cycle.

Authors:  Gabriel L Galea; Lee B Meakin; Marie A Harris; Peter J Delisser; Lance E Lanyon; Stephen E Harris; Joanna S Price
Journal:  Gene       Date:  2016-11-10       Impact factor: 3.688

5.  Wnt co-receptors Lrp5 and Lrp6 differentially mediate Wnt3a signaling in osteoblasts.

Authors:  Aimy Sebastian; Nicholas R Hum; Deepa K Murugesh; Sarah Hatsell; Aris N Economides; Gabriela G Loots
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

6.  Syndecan-3 enhances anabolic bone formation through WNT signaling.

Authors:  Francesca Manuela Johnson de Sousa Brito; Andrew Butcher; Addolorata Pisconti; Blandine Poulet; Amanda Prior; Gemma Charlesworth; Catherine Sperinck; Michele Scotto di Mase; Ke Liu; George Bou-Gharios; Robert Jurgen van 't Hof; Anna Daroszewska
Journal:  FASEB J       Date:  2021-04       Impact factor: 5.191

7.  Transcriptional Regulation of Frizzled-1 in Human Osteoblasts by Sp1.

Authors:  Shibing Yu; Laura M Yerges-Armstrong; Yanxia Chu; Joseph M Zmuda; Yingze Zhang
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

8.  Gastrodin alleviates glucocorticoid induced osteoporosis in rats via activating the Nrf2 signaling pathways.

Authors:  Shengye Liu; Long Zhou; Liyu Yang; Shuai Mu; Tao Fang; Qin Fu
Journal:  Oncotarget       Date:  2018-01-03

9.  Gastrodin protects MC3T3-E1 osteoblasts from dexamethasone-induced cellular dysfunction and promotes bone formation via induction of the NRF2 signaling pathway.

Authors:  Shengye Liu; Tao Fang; Liyu Yang; Zhiguang Chen; Shuai Mu; Qin Fu
Journal:  Int J Mol Med       Date:  2018-01-23       Impact factor: 4.101

10.  Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease.

Authors:  Joséphine Muller; Arnold Bolomsky; Sophie Dubois; Elodie Duray; Kathrin Stangelberger; Erwan Plougonven; Margaux Lejeune; Angélique Léonard; Caroline Marty; Ute Hempel; Frédéric Baron; Yves Beguin; Martine Cohen-Solal; Heinz Ludwig; Roy Heusschen; Jo Caers
Journal:  Haematologica       Date:  2018-05-10       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.